Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Cadila gets USFDA nod for swelling reducing drug

      Zydus Cadila gets USFDA nod for swelling reducing drug

      Ruby Khatun Khatun20 Nov 2017 10:02 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
      Gene therapy becomes reality, but at a price tag of 1 million dollar

      Gene therapy becomes reality, but at a price tag of 1 million dollar

      Ruby Khatun Khatun20 Nov 2017 9:45 AM IST
      LONDON: Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare...
      FDA backs Roche Gazyva in first-line follicular lymphoma

      FDA backs Roche Gazyva in first-line follicular lymphoma

      Ruby Khatun Khatun20 Nov 2017 9:30 AM IST
      ZURICH: The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma,...
      FDA approves new therapy for some hemophilia patients

      FDA approves new therapy for some hemophilia patients

      Ruby Khatun Khatun19 Nov 2017 11:00 AM IST
      TRENTON, N.J.: U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with...
      Cipla gets FDA approval for generic Pulmicort Respules to treat asthma

      Cipla gets FDA approval for generic Pulmicort Respules to treat asthma

      Ruby Khatun Khatun19 Nov 2017 10:01 AM IST
      New Delhi: Drug major Cipla said it has received final approval from the US health regulator for a suspension product used for the treatment of...
      Johnson and Johnson wins California lawsuit claiming asbestos in talc caused cancer

      Johnson and Johnson wins California lawsuit claiming asbestos in talc caused cancer

      Ruby Khatun Khatun19 Nov 2017 10:00 AM IST
      A California jury on Thursday ruled in favor of Johnson and Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being...
      Patanjali group to set up food park in Telangana

      Patanjali group to set up food park in Telangana

      Ruby Khatun Khatun19 Nov 2017 9:45 AM IST
      Hyderabad: Yoga guru Ramdev-led Patanjali group signed a MoU with the Telangana government for setting up a "large" food park in the state.TRS Lok...
      Ahluwalia Contracts bags orders worth Rs 311 crore

      Ahluwalia Contracts bags orders worth Rs 311 crore

      Ruby Khatun Khatun19 Nov 2017 9:30 AM IST
      New Delhi: Ahluwalia Contracts (India) said it has bagged new construction orders worth almost Rs 311 crore.The company said in a BSE filing that it...
      Europe approves GlaxoSmithKlines new triple lung drug

      Europe approves GlaxoSmithKlines new triple lung drug

      Ruby Khatun Khatun19 Nov 2017 9:15 AM IST
      LONDON: Europe has approved GlaxoSmithKline's new three-in-one inhaler for chronic lung disease, which the group hopes will help it keep its lead in...
      Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report

      Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report

      Ruby Khatun Khatun18 Nov 2017 4:31 PM IST
      MUMBAI: Eris Life Sciences is going to acquire Stride Shasun India branded formulations business as the company has agreed to sell it for Rs 500 crore...
      Johnson and Johnson hit with whooping 247 million dollar fine for defective hip implants

      Johnson and Johnson hit with whooping 247 million dollar fine for defective hip implants

      Ruby Khatun Khatun18 Nov 2017 2:24 PM IST
      NEW YORK: A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who...
      Glenmark Pharmaceuticals launches nicotine gum Kwitz

      Glenmark Pharmaceuticals launches nicotine gum Kwitz

      Ruby Khatun Khatun18 Nov 2017 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals said it has launched nicotine replacement therapy product Kwitz that helps smokers quit smoking.Kwitz nicotine gum...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok